In this GEN webinar, Jeremy Tomlinson, PhD, will discuss the pathogenesis of MASLD, share examples from recent research that ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...

The most frequent liver cancers are hepatocellular carcinoma and hepatoblastoma (formed by immature liver cells). Locoregional treatment of hepatocellular carcinoma (HCC) using hepatic arterial ...

An increasing number of basic research studies suggest that the immune system is heavily involved in various causes of hepatocellular carcinoma (eg, hepatocellular carcinoma related to hepatitis B ...

In clinical practice, however, many patients with stage C hepatocellular carcinoma have poor performance status and therefore do not have the chance to receive effective treatment. To address this ...

This study was a multipurposed review, which included discussion of recent studies investigating the cellular and genetic basis of these diseases, the pathogenesis of NAFLD and the current ...

It’s poorly understood how renal manifestations develop in HEV infection in patients. Here, the authors observe glomerular accumulation of the viral protein ORF2 in complex with host IgG in ...

The rising incidence of NAFLD and NASH in children has paralleled the dramatic increase in obesity in this age group. Lifestyle changes for American children, including increased use of computers ...

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...